ZOLID Pioglitazone HCl 30mg 1 Tablet [PRESCRIPTION REQUIRED]
Anti-Diabetic Indication: For the improvement of glycemic control in patients with Type 2 Diabetes Mellitus (NIDDM) inadequately controlled by diet and exercise. As dual oral therapy in adult patients with metformin, or sulfonylurea in insufficient glycemic control.
Place of Origin
PAKISTAN
Product Usage
ZolidMonotherapy15 or 30 mg once daily.Combination therapy15 or 30 mg once daily.Patient at risk of hypoglycemia or w/ hepatic impairmentMax dose: 45 mg once daily.ZolidPlusPatient inadequately controlled on metformin monotherapy15 mg/500 mg once or bid.Patient who initially responded to pioglitazone monotherapy require additional glycemic control15 mg/500 mg once or bid.Patient switching from combination therapy of pioglitazone plus metformin as separate tab15 mg/500 mg once or bid.May be taken with or without food.
Ingredients
Pioglitazone HCl
Warnings
STORAGE
Store at temperatures not exceeding 30øC.
Protect from light and moisture.
The expiration date refers to the product correctly stored at the
required conditions
Width
1
Height
1
Depth
1